Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Dyslipidemia

  Free Subscription


Articles published in Curr Opin Lipidol

Retrieve available abstracts of 58 articles:
HTML format



Single Articles


    April 2024
  1. RASMUSSEN KL, Frikke-Schmidt R
    The current state of apolipoprotein E in dyslipidemia.
    Curr Opin Lipidol. 2024;35:78-84.
    PubMed     Abstract available


  2. WEN Y, Chen YQ, Konrad RJ
    Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism.
    Curr Opin Lipidol. 2024;35:58-65.
    PubMed     Abstract available


    February 2024
  3. PAPONJA K, Pecin I, Reiner Z, Banach M, et al
    Bempedoic acid: new evidence and recommendations on use.
    Curr Opin Lipidol. 2024;35:41-50.
    PubMed     Abstract available


  4. ZHANG Y, de Ferranti SD, Moran AE
    Genetic testing for familial hypercholesterolemia.
    Curr Opin Lipidol. 2024 Feb 1. doi: 10.1097/MOL.0000000000000925.
    PubMed     Abstract available


    December 2023
  5. PERERA SD, Hegele RA
    Genetic variation in apolipoprotein A-V in hypertriglyceridemia.
    Curr Opin Lipidol. 2023 Dec 21. doi: 10.1097/MOL.0000000000000916.
    PubMed     Abstract available


  6. ROMERO-JIMENEZ MJ, Mansilla-Rodriguez ME, Gutierrez-Cortizo EN
    Predictors of cardiovascular risk in familial hypercholesterolemia.
    Curr Opin Lipidol. 2023;34:272-277.
    PubMed     Abstract available


  7. GILLARD BK, Rosales C, Gotto AM Jr, Pownall HJ, et al
    The pathophysiology of excess plasma-free cholesterol.
    Curr Opin Lipidol. 2023;34:278-286.
    PubMed     Abstract available


  8. KARALIS DG
    Strategies of improving adherence to lipid-lowering therapy in patients with atherosclerotic cardiovascular disease.
    Curr Opin Lipidol. 2023;34:252-258.
    PubMed     Abstract available


    November 2023
  9. ROY G, Drouin-Chartier JP
    Cardiovascular disease prevention in heterozygous familial hypercholesterolemia: how important is a healthy diet in the era of long-lasting cholesterol-lowering drug therapies?
    Curr Opin Lipidol. 2023 Nov 2. doi: 10.1097/MOL.0000000000000908.
    PubMed     Abstract available


    October 2023
  10. CHATTOPADHYAY A, Reddy ST, Fogelman AM
    The multiple roles of lysophosphatidic acid in vascular disease and atherosclerosis.
    Curr Opin Lipidol. 2023;34:196-200.
    PubMed     Abstract available


    August 2023
  11. CHOUDHARI P, Patni N
    Updates in the management of pediatric dyslipidemia.
    Curr Opin Lipidol. 2023;34:156-161.
    PubMed     Abstract available


    June 2023
  12. GANDA OP
    Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease.
    Curr Opin Lipidol. 2023;34:105-113.
    PubMed     Abstract available


  13. WADSTROM BN, Pedersen KM, Wulff AB, Nordestgaard BG, et al
    Inflammation compared to low-density lipoprotein cholesterol: two different causes of atherosclerotic cardiovascular disease.
    Curr Opin Lipidol. 2023;34:96-104.
    PubMed     Abstract available


    April 2023
  14. CLARKE SL
    Does low-density lipoprotein fully explain atherosclerotic risk in familial hypercholesterolemia?
    Curr Opin Lipidol. 2023;34:52-58.
    PubMed     Abstract available


  15. HEGELE RA
    DNA testing in dyslipidemia: attitudes and complexities.
    Curr Opin Lipidol. 2023;34:33-34.
    PubMed    


    March 2023
  16. VUORIO A, Raal F, Kovanen PT
    Familial hypercholesterolemia: The nexus of endothelial dysfunction and lipoprotein metabolism in COVID-19.
    Curr Opin Lipidol. 2023 Mar 10. doi: 10.1097/MOL.0000000000000876.
    PubMed     Abstract available


    February 2023
  17. HANG SMT, Hegele RA, Berberich AJ
    Genetic determinants of pancreatitis: relevance in severe hypertriglyceridemia.
    Curr Opin Lipidol. 2023 Feb 2. doi: 10.1097/MOL.0000000000000866.
    PubMed     Abstract available


    January 2023
  18. REIJMAN MD, Defesche JC, Wiegman A
    Genotype-phenotype correlation in a large cohort of pediatric patients with heterozygous and homozygous familial hypercholesterolemia.
    Curr Opin Lipidol. 2023 Jan 18. doi: 10.1097/MOL.0000000000000863.
    PubMed     Abstract available


    December 2022
  19. DRON JS
    The clinical utility of polygenic risk scores for combined hyperlipidemia.
    Curr Opin Lipidol. 2022 Dec 28. doi: 10.1097/MOL.0000000000000865.
    PubMed     Abstract available


  20. WEI T, Cho L
    Recent lipoprotein(a) trials.
    Curr Opin Lipidol. 2022;33:301-308.
    PubMed     Abstract available


  21. MENDOZA MF, Lavie CJ
    Clinical associations between exercise and lipoproteins.
    Curr Opin Lipidol. 2022;33:364-373.
    PubMed     Abstract available


  22. TRAMONTANO D, Bini S, D'Erasmo L, Arca M, et al
    Recent Apolipoprotein CIII trials.
    Curr Opin Lipidol. 2022;33:309-318.
    PubMed     Abstract available


    October 2022
  23. TROMP TR, Cuchel M
    New algorithms for treating homozygous familial hypercholesterolemia.
    Curr Opin Lipidol. 2022 Oct 5. pii: 00041433-990000000-00014.
    PubMed     Abstract available


  24. SCIPIONE CA, Cybulsky MI
    Early atherogenesis: new insights from new approaches.
    Curr Opin Lipidol. 2022;33:271-276.
    PubMed     Abstract available


    August 2022
  25. MARTINS J, Rossouw HM, Pillay TS
    How should low-density lipoprotein cholesterol be calculated in 2022?
    Curr Opin Lipidol. 2022;33:237-256.
    PubMed     Abstract available


    July 2022
  26. LEREN TP, Bogsrud MP
    Cascade screening for familial hypercholesterolemia should be organized at a national level.
    Curr Opin Lipidol. 2022 Jul 13. pii: 00041433-990000000-00004.
    PubMed     Abstract available


  27. DURRINGTON PN, Bashir B, Bhatnagar D, Soran H, et al
    Lipoprotein (a) in familial hypercholesterolaemia.
    Curr Opin Lipidol. 2022 Jul 13. pii: 00041433-990000000-00005.
    PubMed     Abstract available


  28. PAQUETTE M, Bernard S, Baass A
    Diagnosis of remnant hyperlipidaemia.
    Curr Opin Lipidol. 2022 Jul 13. pii: 00041433-990000000-00002.
    PubMed     Abstract available


    June 2022
  29. THEROND P, Chapman MJ
    Sphingosine-1-phosphate: metabolism, transport, atheroprotection and effect of statin treatment.
    Curr Opin Lipidol. 2022;33:199-207.
    PubMed     Abstract available


    April 2022
  30. WHITTAKER MN, Musunuru K
    Therapeutic application of genome editing in dyslipidemia.
    Curr Opin Lipidol. 2022;33:133-138.
    PubMed     Abstract available


    February 2022
  31. SACKS FM, Andraski AB
    Dietary fat and carbohydrate affect the metabolism of protein-based high-density lipoprotein subspecies.
    Curr Opin Lipidol. 2022;33:1-15.
    PubMed     Abstract available


    December 2021
  32. ANTONIAZI L, Arroyo-Olivares R, Mata P, Santos RD, et al
    Association of dietary patterns and components with atherosclerosis risk biomarkers in familial hypercholesterolemia.
    Curr Opin Lipidol. 2021 Dec 13. pii: 00041433-900000000-99240.
    PubMed     Abstract available


  33. MEDEIROS AM, Bourbon M
    Polygenic contribution for familial hypercholesterolemia (FH).
    Curr Opin Lipidol. 2021;32:392-395.
    PubMed     Abstract available


  34. CHAN DC, Ying Q, Watts GF
    Recent dynamic studies of the metabolism of atherogenic lipoproteins: elucidating the mode of action of new therapies.
    Curr Opin Lipidol. 2021;32:378-385.
    PubMed     Abstract available


  35. MATA P, Alonso R, Perez de Isla L, Badimon L, et al
    Dyslipidemia and aortic valve disease.
    Curr Opin Lipidol. 2021;32:349-354.
    PubMed     Abstract available


  36. KERSTEN S
    ANGPTL3 as therapeutic target.
    Curr Opin Lipidol. 2021;32:335-341.
    PubMed     Abstract available


    October 2021
  37. GILL PK, Hegele RA
    Familial combined hyperlipidemia is a polygenic trait.
    Curr Opin Lipidol. 2021 Oct 22. pii: 00041433-900000000-99252.
    PubMed     Abstract available


  38. MCINTOSH CS, Watts GF, Wilton SD, Aung-Htut MT, et al
    Splice correction therapies for familial hypercholesterolemic patients with low-density lipoprotein receptor mutations.
    Curr Opin Lipidol. 2021 Oct 15. pii: 00041433-900000000-99253.
    PubMed     Abstract available


  39. GRAHAM DF, Raal FJ
    Management of familial hypercholesterolemia in pregnancy.
    Curr Opin Lipidol. 2021 Oct 6. pii: 00041433-900000000-99256.
    PubMed     Abstract available


    September 2021
  40. THOMPSON GR
    Use of apheresis in the age of new therapies for familial hypercholesterolaemia.
    Curr Opin Lipidol. 2021 Sep 22. pii: 00041433-900000000-99259.
    PubMed     Abstract available


    August 2021
  41. IQBAL Z, Bashir B, Ferdousi M, Kalteniece A, et al
    Lipids and peripheral neuropathy.
    Curr Opin Lipidol. 2021;32:249-257.
    PubMed     Abstract available


  42. DRON JS, Hegele RA
    Editorial: Discussing polygenic risk with lipid clinic patients.
    Curr Opin Lipidol. 2021;32:273-275.
    PubMed    


    June 2021
  43. BERBERICH AJ, Hegele RA
    Lipid effects of glucagon-like peptide 1 receptor analogs.
    Curr Opin Lipidol. 2021;32:191-199.
    PubMed     Abstract available


    April 2021
  44. MOHAMED F, Botha TC, Raal FJ
    Inhibition of angiopoietin-like 3 for the management of severe hypercholesterolemia.
    Curr Opin Lipidol. 2021 Apr 20. pii: 00041433-900000000-99277.
    PubMed     Abstract available


  45. PULIPATI VP, Davidson MH
    The clinical black, white, and gray lessons.
    Curr Opin Lipidol. 2021;32:151-156.
    PubMed     Abstract available


  46. WAND H, Knowles JW, Clarke SL
    The need for polygenic score reporting standards in evidence-based practice: lipid genetics use case.
    Curr Opin Lipidol. 2021;32:89-95.
    PubMed     Abstract available


  47. BROWN EE
    The genetic counselor's role in management of patients with dyslipidemia.
    Curr Opin Lipidol. 2021;32:83-88.
    PubMed     Abstract available


  48. TRINDER M, Brunham LR
    Polygenic scores for dyslipidemia: the emerging genomic model of plasma lipoprotein trait inheritance.
    Curr Opin Lipidol. 2021;32:103-111.
    PubMed     Abstract available


  49. FONG V, Patel SB
    Recent advances in ABCG5 and ABCG8 variants.
    Curr Opin Lipidol. 2021;32:117-122.
    PubMed     Abstract available


    February 2021
  50. CHORA JR, Bourbon M
    Pharmacogenomics of statins and familial hypercholesterolemia.
    Curr Opin Lipidol. 2021 Feb 10. pii: 00041433-900000000-99283.
    PubMed     Abstract available


    October 2020
  51. YEANG C, Willeit P, Tsimikas S
    The interconnection between lipoprotein(a), lipoprotein(a) cholesterol and true LDL-cholesterol in the diagnosis of familial hypercholesterolemia.
    Curr Opin Lipidol. 2020 Oct 6. doi: 10.1097/MOL.0000000000000713.
    PubMed     Abstract available


  52. IBRAHIM S, Reeskamp LF, Stroes ESG, Watts GF, et al
    Advances, gaps and opportunities in the detection of familial hypercholesterolemia: overview of current and future screening and detection methods.
    Curr Opin Lipidol. 2020 Oct 6. doi: 10.1097/MOL.0000000000000714.
    PubMed     Abstract available


    September 2020
  53. WOLSKA A, Yang ZH, Remaley AT
    Hypertriglyceridemia: new approaches in management and treatment.
    Curr Opin Lipidol. 2020 Sep 29. doi: 10.1097/MOL.0000000000000710.
    PubMed     Abstract available


    June 2020
  54. SORAN H, Cooper JA, Durrington PN, Capps N, et al
    Non-HDL or LDL cholesterol in heterozygous familial hypercholesterolaemia: findings of the Simon Broome Register.
    Curr Opin Lipidol. 2020 Jun 28. doi: 10.1097/MOL.0000000000000692.
    PubMed     Abstract available


  55. BELANGER AM, Akioyamen L, Alothman L, Genest J, et al
    Evidence for improved survival with treatment of homozygous familial hypercholesterolemia.
    Curr Opin Lipidol. 2020 Jun 8. doi: 10.1097/MOL.0000000000000686.
    PubMed     Abstract available


    April 2020
  56. BRANDTS J, Dharmayat KI, Ray KK, Vallejo-Vaz AJ, et al
    Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia?
    Curr Opin Lipidol. 2020 Apr 22. doi: 10.1097/MOL.0000000000000675.
    PubMed     Abstract available


  57. BAJAJ A, Cuchel M
    Homozygous familial hypercholesterolemia: what treatments are on the horizon?
    Curr Opin Lipidol. 2020 Apr 22. doi: 10.1097/MOL.0000000000000677.
    PubMed     Abstract available


    January 2020
  58. D'ERASMO L, Di Costanzo A, Arca M
    Autosomal recessive hypercholesterolemia: update for 2020.
    Curr Opin Lipidol. 2020 Jan 31. doi: 10.1097/MOL.0000000000000664.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.